AstraZeneca Pharma India Ltd

NSE: ASTRAZEN · BSE: 506820 · Pharmaceuticals & Biotechnology · 42 announcements

Share price: ₹5,927.00
Market cap: ₹14,818 Cr
Revenue (annual): ₹2,276 Cr
Net profit (annual): ₹187.5 Cr
P/E (TTM): 87.4×Sector 47.4×
Promoter holding: 75.00%+0.00% QoQ
FII holding: 2.68%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Legal & Regulatory 5 Regulatory Approval 3 Other Announcement 3 Management Change 3 Annual General Meeting 2 Results Update 1 Financial Results 1 Dividend 1 Business Update 1 Board Meeting Date 1 Annual Report 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

3 announcements with these filters

15 Sep 2026 12:00 IST BSE

Management Change

AstraZeneca Pharma India Management Change

AstraZeneca Pharma India's Dr. Sandeep Arora resigned as Director, Medical Affairs, effective September 15, 2026. The company is seeking a suitable replacement for the position.

Read the filing ↗

11 Aug 2026 13:24 IST NSE

Management Change

AstraZeneca Pharma India Management Change

AstraZeneca Pharma India Limited appointed Mr. Arun Krishna as a Non-Executive Director effective August 17, 2026. Additionally, Ms. Bhavana Agrawal transitioned to a Non-Executive Director role.

Read the filing ↗

21 Jul 2026 10:00 IST BSE

Management Change

AstraZeneca Pharma India Management Change

Ms. Bhavana Agrawal has resigned as CFO of AstraZeneca Pharma India Ltd. Her resignation is effective August 31, 2026, to take a regional role.

Read the filing ↗